Guided Therapeutics (GTHP) Times Interest Earned (2016 - 2025)
Historic Times Interest Earned for Guided Therapeutics (GTHP) over the last 16 years, with Q3 2025 value amounting to -$3.76.
- Guided Therapeutics' Times Interest Earned rose 2762.09% to -$3.76 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.87, marking a year-over-year increase of 4002.47%. This contributed to the annual value of -$5.53 for FY2024, which is 5550.71% up from last year.
- As of Q3 2025, Guided Therapeutics' Times Interest Earned stood at -$3.76, which was up 2762.09% from -$4.86 recorded in Q2 2025.
- Guided Therapeutics' 5-year Times Interest Earned high stood at -$0.82 for Q3 2021, and its period low was -$21.81 during Q2 2023.
- For the 5-year period, Guided Therapeutics' Times Interest Earned averaged around -$6.66, with its median value being -$5.19 (2024).
- As far as peak fluctuations go, Guided Therapeutics' Times Interest Earned tumbled by 86317.94% in 2022, and later surged by 5996.01% in 2024.
- Over the past 5 years, Guided Therapeutics' Times Interest Earned (Quarter) stood at -$4.35 in 2021, then plummeted by 211.33% to -$13.54 in 2022, then skyrocketed by 50.26% to -$6.74 in 2023, then soared by 40.84% to -$3.99 in 2024, then rose by 5.66% to -$3.76 in 2025.
- Its Times Interest Earned was -$3.76 in Q3 2025, compared to -$4.86 in Q2 2025 and -$2.82 in Q1 2025.